Unoprostone isopropyl rescues retinal progenitor cells from apoptosis in vitro

Current Eye Research

Volumn 29, Issue 6, 2004, Pages 457-464

  Mukuno, Hirokazu ^a   Nakamura, Makoto ^a   Kanamori, Akiyasu ^a   Nagai, Azusa ^a   Negi, Akira ^a   Seigel, Gail M ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Apoptosis; Docosanoid; Neuroprotection; Retina; Unoprostone isopropyl

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; KT 5823; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; UNOPROSTONE ISOPROPYL ESTER;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GLIA CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL; SIGNAL TRANSDUCTION; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CARBAZOLES; CASPASE 3; CASPASES; CHROMONES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYTOPROTECTION; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; INDOLES; MORPHOLINES; RATS; RETINA; STEM CELLS;

EID: 12344253168     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490889465     Document Type: Article

References (56)

1. Sakurai M, Araie M, Oshika T, et al. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol. 1991;35:156-165.
2. Azuma I, Masuda K, Kitazawa Y, et al. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension. Jpn J Ophthalmol. 1993;37:514-525.
3. Taniguchi T, Haque MS, Sugiyama K, et al. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocur-Pharmacol Ther. 1996;12:489-498.
4. Yamamoto T, Kitazawa Y, Azuma I, et al. Clinical evaluation of UF-021 (Rescula; isopropyl unoprostone). Surv Ophthalmol. 1997;41:S99-S103.
5. Serle JB, Podos SM, Kitazawa Y, et al. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol. 1998;42:95-100.
6. Susanna R Jr, Giampani J Jr, Borges AS, et al. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension. Ophthalmology. 2001;108:259-263.
7. Sugiyama T, Azuma I. Effect of UF-021 on optic nerve head circulation in rabbits. Jpn J Ophthalmol. 1995;39:124-129.
8. Tamaki Y, Araie M, Tomita K, et al. Effect of topical unoprostone on circulation of human optic nerve head and retina. J Ocul Pharmacol Ther. 2001;17:517-527.
9. Makimoto Y, Sugiyama T, Kojima S, et al. Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus. Jpn J Ophthalmol. 2002;46:31-35.
10. Hayami K, Unoki K. Photoreceptor protection against constant light-induced damage by isopropyl unoprostone, a prostaglandin F(2alpha) metabolite-related compound. Ophthalmic Res. 2001;33:203-09.
11. Lafuente M, Mayor-Torroglosa S, Villegas-Perez M, et al. Retinal ganglion cell survival after transient ligation of the ophthalmic vessels and administration of unoprostone isopropyl. Invest Ophthalmol Vis Sci. 2000;41:S15.
12. Marcheselli V, DeCoster M, Cambell Z, et al. Neuroprotection by unoprostone, but not by latanoprost against glutamate-stimulated calcium influx and cell death in retinal ganglion cells. Invest Ophthalmol Vis Sci. 2001;42:S750.
13. Goh Y, Kishino J. Pharmacological characterization of prostaglandin-related ocular hypotensive agents. Jpn J Ophthalmol. 1994;38:236-245.
14. Bhattacherjee P, Paterson CA, Percicot C. Studies on receptor binding and signal transduction pathways of unoprostone isopropyl. J Ocul Pharmacol Ther. 2001;17:433-441.
15. Kelly CR, Williams GW, Sharif NA. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. J Pharmacol Exp Ther. 2003;304:238-245.
16. Melamed S. Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma. Drugs Exp Clin Res. 2002;28:63-73.
17. Thieme H, Stumpff F, Ottlecz A, et al. Mechanisms of action of unoprostone on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2001;42:3193-3201.
18. Sarda N, Gharib A, Moliere P, et al. Docosahexaenoic acid (cervonic acid) incorporation into different brain regions in the awake rat. Neurosci Lett. 1991;123:57-60.
19. Sawazaki S, Salem N Jr, Kim HY. Lipoxygenation of docosahexaenoic acid by the rat pineal body. J Neurochem. 1994;62:2437-2447.
20. Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res. 1983;22:79-131.
21. Bazan NG, Reddy TS. Retina. In : Lajtha A, ed. Handbook of Neurochemistry, Vol. 8. New York: Plenum Press; 1985:209-217.
22. Kim HY, Akbar M, Lau A, et al. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem. 2000;275:35215-35223.
23. Rotstein NP, Politi LE, German OL, et al. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci.2003;44:2252-2259.
24. Kashiwagi K, Iizuka Y, Tsukahara S. Metabolites of isopropyl unoprostone as potential ophthalmic solutions to reduce intraocular pressure in pigmented rabbits. Jpn J Pharmacol. 1999;81:56-62.
25. Kashiwagi K, Jin M, Suzuki M, et al. Isopropyl unoprostone increases the activities of matrix metalloproteinase in cultured monkey ciliary muscle cells. J Glaucoma. 2001;10:271-276.
26. Kashiwagi K, Tsukamoto K, Wakamatsu K, et al. Effects of isopropyl unoprostone on melanogenesis in mouse epidermal melanocytes. Jpn J Ophthalmol. 2001;45:259-263.
27. Seigel GM. Establishment of an E1A-immortalized retinal cell culture. In Vitro Cell Dev Biol Anim. 1996;32:66-68.
28. Tezel G, Wax MB. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci. 2000;20:3552-3562.
29. Barber AJ, Nakamura M, Wolpert EB, et al. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem. 2001;276:32814-32821.
30. Nakamura M, Barber AJ, Antonetti DA, et al. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem. 2001;276:43748-43755.
31. Seigel GM, Mutchler AE, Adamus G, et al. Recoverin expression in the R28 retinal precursor cell line. In Vitro Cell Dev Biol Anim. 1997;33:499-502.
32. Tezel GM, Seigel GM, Wax MB. Density-dependent resisitance to apoptosis in retinal cells. Curr Eye Res. 1999;19:377-388.
33. Xu L, Ma J, Seigel GM, et al. 1-Deprenyl blocking apoptosis and regulating gene expression in cultured retinal neurons. Biochem Pharmacol. 1999;58:1183-1190.
34. Tezel G, Wax MB. Inhibiton of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci. 1999;40:2660-2667.
35. Sun W, Seigel GM, Salvi RJ. Retinal precursor cells express functional ionotropic glutamate and GABA receptors. Neuroreport. 2002;13:2421-2424.
36. Reber F, Kasper M, Siegner A, et al. Alteration of the intracellular pH and apoptosis induction in a retinal cell line by the AGE-inducing agent glyoxal. Graefe's Arch Clin Exp Ophthalmol. 2002;240:1022-1032.
37. Allsopp TE. Transduction of survival signals in neuronstake your PIK? Trends Neurosci. 2000;23:593.
38. Rodgers EE, Theibert AB. Functions of PI3-kinase in development of the nervous system. Int J Dev Neurosci. 2002;20:187-197.
39. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231-241.
40. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318-1321.
41. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857-868.
42. Kim AH, Khursigara G, Sun X, et al. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol. 2001;21:893-901.
43. Fiscus RR. Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals. 2002;11:175-190.
44. Hawkins RD, Son H, Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res. 1998;118:155-172.
45. Fiscus RR, Robles BT, Waldman SA, et al. Atrial natriuretic factors stimulate accumulation and efflux of cyclic GMP in C6-2B rat glioma and PC12 rat pheochromocytoma cell cultures. J Neurochem. 1987;48:522-528.
46. Estevez AG, Spear N, Thompson JA, et al. Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J Neurosci. 1998;18:3708-3714.
47. Takuma K, Phuagphong P, Lee E, et al. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem. 2001;276:48093-48099.
48. Kim YM, Chung HT, Kim SS, et al. Nitric oxide protects PC 12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci. 1999;19:6740-6747.
49. Gribkoff VK, Starrett JE Jr, Dworetzky SI. Maxi-K potassium channels: form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist. 2001;7:166-177.
50. Drago F, Valzelli S, Emmi I, et al. Latanoprost exerts neuroprotective activity in vitro and in vivo. Exp Eye Res. 2001;72:479-486.
51. Mizuno K, Koide T, Yoshimura M, et al. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci. 2001;42:688-694.
52. Tomita H, Nakazawa T, Sugano E, et al. Nipradilol inhibits apoptosis by preventing the activation of caspase-3 via S-nitrosylation and the cGMP-dependent pathway. Eur J Pharmacol. 2002;452:263-268.
53. Goto W, Ota T, Morikawa N, et al. Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina. Brain Res. 2002;958:10-19.
54. Wood JP, Schmidt KG, Melena J, et al. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res. 2003;76:505-516.
55. Ambati J, Adamis AP. Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res. 2002;21:145-151.
56. Boubriak OA, Urban JP, Bron AJ. Differential effects of aging on transport properties of anterior and posterior human sciera. Exp Eye Res. 2003;76:701-713.